Federal Official Gazette
OPERATIONAL RESOLUTION ANS No. 3,132, OF MAY 15, 2026: Provides for the decree of extrajudicial liquidation of the operator VIDAPLAN SAÚDE LTDA – EPP.
OPERATIONAL RESOLUTION ANS No. 3,131, OF MAY 15, 2026: Provides for the suspension of the transfer of the portfolio of AMPLA PLANOS DE SAÚDE LTDA.
OPERATIONAL RESOLUTION ANS No. 3,134, OF MAY 15, 2026: Provides for the order to transfer the portfolio of the operator CENTRAL OPERADORA DE PLANOS DE SAÚDE NORTE-NORDESTE LTDA.
OPERATIONAL RESOLUTION ANS No. 3,133, OF MAY 15, 2026: Provides for the order to transfer the portfolio of the operator PRESERVE SAÚDE ASSISTÊNCIA MÉDICA LTDA.
OPERATIONAL RESOLUTION ANS No. 3,135, OF MAY 15, 2026: Provides for the granting of special portability of waiting periods to the beneficiaries of the operator UNIMED OESTE DO PARÁ – COOPERATIVA DE TRABALHO MÉDICO, ANS Registration No. 36.214-0.
INTERNAL RULES RESOLUTION ANS No. 37, OF MAY 15, 2026: Amends the main text, replaces Annex I and Annexes I-a, I-b, I-c, I-d, I-e, I-f, I-h, I-i and I-j, all of Internal Rules Resolution No. 21, of January 26, 2022, which provides for the Internal Rules of the National Supplementary Health Agency – ANS.
Note:
RR No. 37/2026 is an internal rules act of broad scope, but with substantive impact concentrated on three main axes.
The first is the regulatory procedure axis: the codification of the duty to observe Decree No. 10,411/2020 in the ASSNT/DIFIS (Annex I-c), combined with the express assignment to ASDIM of the task of supporting AIR and ARR (Annex I-a), strengthens the argument that failure to follow the AIR procedure in ANS Public Consultation No. 170 is not a mere procedural irregularity, but a breach of an obligation internally recognized by the agency itself.
The second is the contracting axis: the creation of ATIOC and the delimitation of the powers of GEIQP/DICTT (Annex I-d) institutionalize, within DIDES, a structure dedicated to the subject of the operator-contracting party and operator-provider relationship — the subject of CP No. 170.
The third is the technology axis: the creation of CGTEC and the rewriting of art. 29 (GETSI) formalize an AI governance and digital transformation agenda that ANS had not yet codified in its internal rules, with possible regulatory developments concerning operators’ obligations on information security.
See the full study in the attachment.
ANS news
Decisions of the 637th Meeting of the Board of Directors
ITEM 1 – Approval of the draft minutes of the 6th Extraordinary Meeting of the Board of Directors of 2026 and of the 636th Ordinary Meeting of the Board of Directors, held on Apr 17 and 24, respectively. DECISION: ITEM APPROVED.
ITEM 2 DIDES – Report on the 3rd Call for Proposals of the Comprehensive Health Care Project – Development and Implementation of the Network-Coordinated Care Model (Macor).
ITEM 3 PRESI – Consideration of Conclusive Report 2/2026/COINQ/SECEX/PRESI on the former operator Associação Auxiliadora das Classes Laboriosas.
ITEM 4 PRESI – Consideration of Conclusive Report 3/2026/COINQ/SECEX/PRESI on the former operator Associação de Saúde dos Policiais e Bombeiros Militares do Espírito Santo (ASPBMES).
ITEM 5 DIPRO – Approval of the proposal to temporarily suspend the processing of the Care Risk Mapping (Mapeamento do Risco Assistencial) due to its methodological restructuring.
ITEM 6 DIPRO – Consideration of the Regulatory Outcome Analysis (ARR) regarding Normative Resolution (RN) 438/2018 and approval of the holding of a public hearing.
ITEM 7 DIGES – Approval of the proposed Administrative Resolution governing the Special Accounts Procedure (Tomada de Contas Especial) – in response to ANS’s internal audit.
ITEM 8 DIGES – Approval of the proposed Internal Rules Resolution (RR) amending RR 21/2022 and its annexes, in line with Decree 12,934/2026.
ITEM 9 DIFIS – Approval of the proposed declaration of compliance with Conduct Adjustment Commitment Agreement (TCAC) 1/2024 by the company Preserve Saúde Assistência Médica LTDA., ANS registration 42.295-9.
ITEMS 10 AND 11 DIFIS – Approval of the proposals to enter into TCACs between ANS and the Associação Comercial e Empresarial do Espírito Santo (ACE-ES), without ANS registration, registered under CNPJ 03.077.236/0001-14, and between ANS and the Associação das Empresas e Funcionários do Comércio de Bens e Serviços no Estado do Espírito Santo (ACS-ES), also without ANS registration, registered under CNPJ 14.145.515/0001-94.
ITEM 12 OFF-AGENDA DIPRO – Decision on the administrative appeal filed by Edwards Lifesciences Comércio de Produtos Médico-Cirúrgicos LTDA. regarding the non-inclusion in the List of Health Procedures and Events (Rol) – Technical Analysis Unit (UAT) 160.
ITEM 13 OFF-AGENDA DIPRO – Decision on a health technology positively recommended by the National Commission for the Incorporation of Technologies in the Unified Health System (Conitec) for incorporation into the Unified Health System (SUS). Technology for inclusion in the List of Health Procedures and Events (Rol).
ITEM 14 OFF-AGENDA DIPRO – Decision on the proposed update of the List of Health Procedures and Events (Rol). Return from Public Consultation. Consideration of the Final Recommendation Technical Note (NTRF) regarding UAT 193.
ITEM 15 OFF-AGENDA DIDES – Approval of the extension of the deadline of Public Consultation 170, which addresses the proposed new RN on Contracting between private health care plan operators and health care service providers.
BLOCK (BLOCÃO) – 204 proceedings were placed on the agenda, four of which were withdrawn for adjustments, and all the others were approved.
Open public consultations
- CP 172. Aims to receive contributions on the proposed updates to the List of Health Procedures and Events (Rol). Period: May 13, 2026 to Jun 2, 2026.
Scheduled public hearings
- New: AP 66. Collection of contributions on the preliminary recommendation of non-incorporation for the following technologies: UAT 188 – Bimekizumab for the treatment of moderate to severe active hidradenitis suppurativa in adults who failed, were intolerant to or had a contraindication to systemic antibiotic therapy; and UAT 198 – Capivasertib for the treatment of locally advanced or metastatic breast cancer, HR+ and HER2-, with one or more alterations in PIK3CA/AKT1/PTEN. Date: May 22, 2026, from 9:30 a.m. to 12:30 p.m.
Open public calls for input
There is no open public call for input.
Open public calls
No updates.
Other news
– No updates.
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.